EIC Q4 2025 Earnings Narrow EPS Miss but Positive Stock Suggests Investor Confidence ON24 Q4 2025 Earnings Strong EPS Beat Drives Positive Stock Movement HMY Q2 2016 Earnings EPS Misses Estimates by Wide Margin Amid Cost Pressures NDAQ Q1 2026 Earnings EPS Beats Estimates by 111 Revenue Not Disclosed Shares Edge Higher XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles AsiaPacific Markets Rise as USIran Nuclear Talks Face New Hurdles